|
|
TAK 285
Description of:TAK 285
TAK-285 is currently under clinical development. TAK-285 may have a unique role in the treatment of brain lesions ...
More>>
|
|
|
|
Bafetinib(INNO-406)
Description of:Bafetinib(INNO-406)
Bafetinib (INNO-406) is an orally available, dual Abl/Lyn kinase inhibitor that is up to 55-times more poten...
More>>
|
|
|
|
CP-547632
Theoretical analysis:CP-547632
MF:C20H24BrF2N5O3S
MW:532.408
CAS:252003-65-9
Availability and price:CP-547632More>>
|
|
|
|
AZD4547
Description of:AZD4547
FGFR inhibitor AZD4547 binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal trans...
More>>
|
|
|
|
Imatinib Mesylate
Description of:Imatinib Mesylate
Inhibition of CSF-1R by imatinib is competitive with ATP, with a Ki value of 120 nM. Imatinib also stimulates ...
More>>
|
|
|
|
LDN193189
Description of:LDN193189
A highly potent small molecule BMP inhibitor; inhibiting BMP type I receptors ALK2 (IC50: 5 nM), ALK3 (IC50: 30 nM) an...
More>>
|
|
|
|
ALK5 INHIBITOR
Theoretical analysis:ALK5 INHIBITOR
Formula:C17H13N5
Solubility:Soluble to 100 mM in DMSO and to 50 mM in ethanol
Purity:>99 %...
More>>
|
|
|
|
INCB28060
Description of:INCB28060
Oral dosing of INCB28060 results in time- and dose-dependent inhibition of c-MET phosphorylation and tumor growth in c...
More>>
|
|
|
|
BMS-599626
Description of:BMS-599626
BMS-599626 inhibits human epidermal growth factor receptors (HER) HER1, HER2 and HER4, thereby inhibiting the prolife...
More>>
|
|
|
|
BIBF1120
Description of:BIBF1120
BIBF 1120 inhibits mitogen-activated protein kinase and Akt signaling pathways in three cell types contributing t...
More>>
|
|
Neuronal Signaling
BtK
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian